沙眼衣原体:细胞生物学、免疫学与疫苗研发
沙眼衣原体是高度流行的性传播细菌病原体,可导致严重并发症;现有治疗虽能治愈疾病,但患者不产生保护性免疫,且多数无症状患者不求医。本文综述沙眼衣原体的胞内生物学与免疫逃逸机制、动物模型和人类中的免疫保护相关因素,以及既往疫苗研究的成败,提出疫苗开发的关键要素与潜在解决方案。
要点
- 沙眼衣原体感染治疗成功但不产生保护性免疫,无症状患者不治疗,亟需广谱保护性疫苗。
- 疫苗开发依赖三大要素:衣原体生物学与免疫逃逸、保护相关因素、既往疫苗尝试的反思。
- CD4+ T淋巴细胞和B淋巴细胞反应是清除病原体的关键免疫保护相关因素。
核心结论
- 沙眼衣原体感染需要广谱保护性疫苗以预防传播和症状性疾病,疫苗开发应基于生物学、免疫保护相关因素和既往疫苗研究的综合洞察。
研究设计与样本
- 综述:概述沙眼衣原体胞内生物学与免疫逃逸适应,探讨动物模型和人类中衣原体免疫及保护相关因素,梳理疫苗研究时间线并评估成败。
主要发现
- 沙眼衣原体具有独特的胞内生物学和动态适应组合,可颠覆宿主免疫并在细胞内生存。
- CD4+ T淋巴细胞和B淋巴细胞反应是病原体清除的关键免疫保护相关因素。
临床怎么用
- 提示预防医学与公共卫生应关注沙眼衣原体疫苗研发进展,并重视无症状感染者不寻求治疗带来的传播风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chlamydia trachomatis is the causative agent of a highly prevalent sexually transmitted bacterial disease and is associated with a number of severe disease complications. Current therapy options are successful at treating disease, but patients are left without protective immunity and do not benefit the majority asymptomatic patients who do not seek treatment. As such, there is a clear need for a broad acting, protective vaccine that can prevent transmission and protect against symptomatic disease presentation. There are three key elements that underlie successful vaccine development: 1) Chlamydia biology and immune-evasion adaptations, 2) the correlates of protection that prevent disease in natural and experimental infection, 3) reflection upon the evidence provided by previous vaccine attempts. In this review, we give an overview of the unique intra-cellular biology of C. trachomatis and give insight into the dynamic combination of adaptations that allow Chlamydia to subvert host immunity and survive within the cell. We explore the current understanding of chlamydial immunity in animal models and in humans and characterise the key immune correlates of protection against infection. We discuss in detail the specific immune interactions involved in protection, with relevance placed on the CD4+ T lymphocyte and B lymphocyte responses that are key to pathogen clearance. Finally, we provide a timeline of C. trachomatis vaccine research to date and evaluate the successes and failures in development so far. With insight from these three key elements of research, we suggest potential solutions for chlamydial vaccine development and promising avenues for further exploration.
引用
- Murray SM, McKay PF. Chlamydia trachomatis: Cell biology, immunology and vaccination. Vaccine. 2021. PMID: 33771390. doi:10.1016/j.vaccine.2021.03.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。